-
The Future of Biomarker-Guided Therapy for Heart Failure After the Guiding Evidence-Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) StudyIbrahim NE, Januzzi JL Jr. -
The pyruvate-lactate axis modulates cardiac hypertrophy and heart failureAA Cluntun, R Badolia, SG Drakos et al.
-
Impact of Myocardial Scar on Prognostic Implication of Secondary Mitral Regurgitation in Heart FailureB Tayal, D Debs, F Nabi et al.
-
Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trialVelazquez EJ, Morrow DA, DeVore AD et al.
-
In acute HF and iron deficiency, IV ferric carboxymaltose reduced HF hospitalizations, but not CV death, at 1 yEM DeFilippis, HGC Van Spall.
-
Heart Failure With Preserved Ejection Fraction in the YoungJ Tromp , MR MacDonald, CSP Lam et al.
-
Cardiac Resynchronization Therapy and Ventricular Tachyarrhythmia BurdenS Tankut, I Goldenberg, V Kutyifa et al.
-
Economic and Quality-of-Life Outcomes of Natriuretic Peptide–Guided Therapy for Heart FailureDB Mark, PA Cowper, KJ Anstrom et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
